Nortropan-3β-essigsaeure | 66734-08-5

• 分子结构分类: 有机化合物 - 生物碱及其衍生物
• 英文名称: Nortropan-3β-essigsaeure
• 英文别名: Nortropan-3α-essigsaeure；2-{8-Azabicyclo[3.2.1]octan-3-yl}acetic acid；2-(8-azabicyclo[3.2.1]octan-3-yl)acetic acid
• CAS: 66734-08-5
• 化学式: C₉H₁₅NO₂
• 分子量: 169.224
• InChiKey: NONWVHGVOWJDBN-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -1.6
• 重原子数：
  12
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.89
• 拓扑面积：
  49.3
• 氢给体数：
  2
• 氢受体数：
  3

文献信息

• Novel piperidine and piperazine derivatives
  申请人：——

  公开号：US20030013721A1

  公开（公告）日：2003-01-16

  The invention provides piperidine and piperazine derivatives of general formula (I), processes for their preparation, pharmaceutical compositions containing them, a process for preparing the pharmaceutical compositions, and their use in therapy 1

  这项发明提供了一般式(I)的吡啶和哌嗪衍生物，其制备方法，含有它们的药物组合物，制备药物组合物的方法，以及它们在治疗中的用途。
• Salts of endo-8-methyl-8-syn-alkyl-8-azoniabicyclo-(3.2.1)-octane-3-alkylcarboxylates, process for their preparation and therapeutic compositions containing them
  申请人：VALEAS S.p.A. INDUSTRIA CHIMICA E FARMACEUTICA

  公开号：EP0042365A1

  公开（公告）日：1981-12-23

  The invention relates to new salts of endo-8-methyl-8-syn- atkyl-8-azoniabicycio-[3.2.1 ]-octane-3-atkylcarboxylates, of formula: in which R1 is a linear or branched alkyl radical of 2-5 C atoms, a cycloalkyl radical of 3-6 C atoms, or a phenyl-alkyl radical, R3 and R4, which can be the same or different, are alkyl radicals of 1-6 C atoms, X is a halide ion. The new compounds are potent spasmolytics.

  本发明涉及内-8-甲基-8-鞘氨酰-8-氮杂双环-[3.2.1 ]-辛烷-3-烷基羧酸盐的新盐，其式如下： 其中 R1 是 2-5 个 C 原子的直链或支链烷基、3-6 个 C 原子的环烷基或苯基烷基，R3 和 R4（可以相同或不同）是 1-6 个 C 原子的烷基，X 是卤化物离子。 新化合物是强效的解痉剂。
• New amidino tricycle derivatives
  申请人：ISTITUTO DE ANGELI S.p.A.

  公开号：EP0309422A2

  公开（公告）日：1989-03-29

  New pharmacologically active amidino tricycle derivatives as muscarinic receptor blocking agents, useful for the treatment of gastrointestinal disorders of the following formula: wherein R represents a hydrogen atom or a halogen atom X represents nitrogen or -CH-group W represents a -NH-CO-, -CH=CH-, -CH₂-CH₂- group, oxygen or sulfur R₁ represents a hydrogen atom or a C₁₋₄ alkyl group n is 0 or 1 Y represents sulfur or a -CH- group A represents carbon or nitrogen B represents a -CH- group (provided that A is different from nitrogen), -COO-, -CO-, or -CH₂- group m is 0 or an integer from 1 to 3 Z represents -NH-, -CO-, -COO- or -CH- group, or it is absent p is 0 or 1 Het represents piperazinyl, homopiperazinyl, piperidinyl, tropyl or tetrahydropirimidinyl group, each group being optionally substituted by a C₁₋₄ alkyl group or an amino group q is 0 or 1 R₂ represents a hydrogen atom, a C₁₋₄ alkyl group or an amino group optionally substituted by a linear or branched C₁₋₄ alkyl group or phenyl group R₃ represents a linear or branched C₁₋₈alkyl group or a hydrogen atom (provided that the bond between Het and the group is a carbon- carbon bond or A=C and B=CH), or R₂ and R₃ may join together to form a heterocyclic 5-membered ring, tautomers thereof and acid addition salts of the aforesaid compounds. The process for the preparation of the compounds of formula (I) as well as pharmaceuticals compositions containing them are also described.

  具有药理活性的新型脒基三环衍生物作为毒蕈碱受体阻断剂，可用于治疗下式所示的胃肠道疾病： 其中 R 代表氢原子或卤原子 X 代表氮或-CH-基团 W 代表-NH-CO-、-CH=CH-、-CH₂-CH₂-基团、氧或硫 R₁ 代表氢原子或 C₁₋₄ 烷基 n 为 0 或 1 Y 代表硫或 -CH- 基团 A 代表碳或氮 B代表-CH-基团（条件是A不同于氮）、-COO-、-CO-或-CH₂-基团 m 是 0 或 1 至 3 的整数 Z代表-NH-、-CO-、-COO-或-CH-基团，或者不代表-NH-、-CO-、-COO-或-CH-基团 p 为 0 或 1 Het 代表哌嗪基、均哌嗪基、哌啶基、托品基或四氢嘧啶基，每个基团可选被 C₁₋₄ 烷基或氨基取代 q 为 0 或 1 R₂ 代表氢原子、C₁₋₄ 烷基或任选被直链或支链 C₁₋₄ 烷基或苯基取代的氨基 R₃ 代表直链或支链 C₁₋₈烷基或氢原子（条件是 Het 与基团之间的键是碳碳键或 A 为碳-碳键或 A=C 和 B=CH），或 R₂ 和 R₃ 可连接在一起形成杂环五元环、其同系物和上述化合物的酸加成盐。 此外，还描述了式 (I) 化合物的制备过程以及含有这些化合物的药物组合物。
• NOVEL PIPERIDINE AND PIPERAZINE DERIVATIVES
  申请人：AstraZeneca AB

  公开号：EP1242427A1

  公开（公告）日：2002-09-25
• NOVEL PIPERIDINE AND PIPERAZINE DERIVATIVES AS P2X7 RECEPTOR ANTAGONISTS
  申请人：AstraZeneca AB

  公开号：EP1242427B1

  公开（公告）日：2003-08-13